Retatrutide is designed to activate GLP-1, GIP, and glucagon receptors (triple agonist), and researchers study how that impacts metabolic endpoints in clinical trials
Several mechanisms have been proposed to explain the beneficial CV effects of SGLT2i, namely reduction of blood pressure and intravascular volume, and reduction of myocardial oxygen consumption, all of which can lead to a decreased workload on the heart and improved cardiac function [86, 107]
Additionally, its action on brain centers that control appetite results in reduced hunger and improved control over eating behaviors
Furthermore, if blood glucose levels drop too low in patients with diabetesparticularly those on concurrent insulin or sulfonylureashypoglycemia can present with tiredness, weakness, and other symptoms
The Precision Peptide Genetic Test can also identify whether genetic factors increase your itching risk, allowing your PlexusDx physician to select the most compatible compound and starting dose for your body
